ca nos3 human mouse monoclonal Search Results


90
Becton Dickinson anti-human enos mouse monoclonal antibody
Anti Human Enos Mouse Monoclonal Antibody, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca+nos3+human+mouse+monoclonal/mouse+monoclonal+anti+enos/pmc02829218-96-9-14
Average 90 stars, based on 1 article reviews
anti-human enos mouse monoclonal antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson purified mouse anti-human enos antibody (610296)
Purified Mouse Anti Human Enos Antibody (610296), supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca+nos3+human+mouse+monoclonal/mouse+anti+human+antibodies+enos/10__1161_slash_atvbaha__112__301068-156-1-12
Average 90 stars, based on 1 article reviews
purified mouse anti-human enos antibody (610296) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Becton Dickinson mouse anti-human enos
Mouse Anti Human Enos, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca+nos3+human+mouse+monoclonal/anti+enos/10__1161_slash_01__cir__0000145608__80855__bc-42-21-25
Average 90 stars, based on 1 article reviews
mouse anti-human enos - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Boster Bio rabbit anti rabbit enos
BMMNC transplantation reverses atherosclerosis-induced changes in antioxidant enzymes, <t>eNOS,</t> inflammatory response, and cell apoptosis. (A) Western blot analysis of eNOS in plaques. (B) Quantification analysis showed that plaques from the BMMNC group contained more eNOS than did plaques from the vehicle group. (C–F) BMMNC transplantation upregulated expression of the antioxidant enzymes GPx-1 and SOD-1 in plaque. (C, E) Western blot analysis of GPx-1 and SOD-1 in plaque. (D, F) Quantification of band densities showed that plaques from rabbits treated with BMMNCs had significantly higher GPx-1 and SOD-1 protein expression than did plaques from vehicle-treated rabbits. (G–H) BMMNC transplantation reduced expression of cell-death marker cleaved caspase-3 in plaque. (G) Western blot analysis of cleaved caspase-3. (H) Quantification analysis showed that cleaved caspase-3 was significantly lower in plaques from BMMNC-treated rabbits than in plaques from vehicle-treated rabbits. *p<0.05 vs. vehicle group. (I–L) BMMNC transplantation significantly decreased the mRNA expression of proinflammatory cytokines in plaque. (I) Representative RT-PCR bands showing mRNA expression of IL-1 β, TNF-α, and MMP-9 in plaque. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. (J–L) Analysis of band optical densities showed that BMMNC transplantation significantly decreased the mRNA expression of IL-1 β, TNF-α, and MMP-9 compared with that in vehicle-treated animals. *p<0.05 vs. vehicle group. n=6 rabbits per group.
Rabbit Anti Rabbit Enos, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca+nos3+human+mouse+monoclonal/Human+Glutathione+Peroxidase+1%2FGPX1(U49C)+Recombinant+Protein/pmc04738171-104-19-23
Average 90 stars, based on 1 article reviews
rabbit anti rabbit enos - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc rabbit anti phospho enos
BMMNC transplantation reverses atherosclerosis-induced changes in antioxidant enzymes, <t>eNOS,</t> inflammatory response, and cell apoptosis. (A) Western blot analysis of eNOS in plaques. (B) Quantification analysis showed that plaques from the BMMNC group contained more eNOS than did plaques from the vehicle group. (C–F) BMMNC transplantation upregulated expression of the antioxidant enzymes GPx-1 and SOD-1 in plaque. (C, E) Western blot analysis of GPx-1 and SOD-1 in plaque. (D, F) Quantification of band densities showed that plaques from rabbits treated with BMMNCs had significantly higher GPx-1 and SOD-1 protein expression than did plaques from vehicle-treated rabbits. (G–H) BMMNC transplantation reduced expression of cell-death marker cleaved caspase-3 in plaque. (G) Western blot analysis of cleaved caspase-3. (H) Quantification analysis showed that cleaved caspase-3 was significantly lower in plaques from BMMNC-treated rabbits than in plaques from vehicle-treated rabbits. *p<0.05 vs. vehicle group. (I–L) BMMNC transplantation significantly decreased the mRNA expression of proinflammatory cytokines in plaque. (I) Representative RT-PCR bands showing mRNA expression of IL-1 β, TNF-α, and MMP-9 in plaque. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. (J–L) Analysis of band optical densities showed that BMMNC transplantation significantly decreased the mRNA expression of IL-1 β, TNF-α, and MMP-9 compared with that in vehicle-treated animals. *p<0.05 vs. vehicle group. n=6 rabbits per group.
Rabbit Anti Phospho Enos, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca+nos3+human+mouse+monoclonal/eNOS+Antibody/pmc03409278-82-0-7
Average 96 stars, based on 1 article reviews
rabbit anti phospho enos - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc enos
BMMNC transplantation reverses atherosclerosis-induced changes in antioxidant enzymes, <t>eNOS,</t> inflammatory response, and cell apoptosis. (A) Western blot analysis of eNOS in plaques. (B) Quantification analysis showed that plaques from the BMMNC group contained more eNOS than did plaques from the vehicle group. (C–F) BMMNC transplantation upregulated expression of the antioxidant enzymes GPx-1 and SOD-1 in plaque. (C, E) Western blot analysis of GPx-1 and SOD-1 in plaque. (D, F) Quantification of band densities showed that plaques from rabbits treated with BMMNCs had significantly higher GPx-1 and SOD-1 protein expression than did plaques from vehicle-treated rabbits. (G–H) BMMNC transplantation reduced expression of cell-death marker cleaved caspase-3 in plaque. (G) Western blot analysis of cleaved caspase-3. (H) Quantification analysis showed that cleaved caspase-3 was significantly lower in plaques from BMMNC-treated rabbits than in plaques from vehicle-treated rabbits. *p<0.05 vs. vehicle group. (I–L) BMMNC transplantation significantly decreased the mRNA expression of proinflammatory cytokines in plaque. (I) Representative RT-PCR bands showing mRNA expression of IL-1 β, TNF-α, and MMP-9 in plaque. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. (J–L) Analysis of band optical densities showed that BMMNC transplantation significantly decreased the mRNA expression of IL-1 β, TNF-α, and MMP-9 compared with that in vehicle-treated animals. *p<0.05 vs. vehicle group. n=6 rabbits per group.
Enos, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca+nos3+human+mouse+monoclonal/eNOS+Rabbit+mAb/ppr0453082-32-6-11
Average 96 stars, based on 1 article reviews
enos - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc anti phospho enos ser1177
BMMNC transplantation reverses atherosclerosis-induced changes in antioxidant enzymes, <t>eNOS,</t> inflammatory response, and cell apoptosis. (A) Western blot analysis of eNOS in plaques. (B) Quantification analysis showed that plaques from the BMMNC group contained more eNOS than did plaques from the vehicle group. (C–F) BMMNC transplantation upregulated expression of the antioxidant enzymes GPx-1 and SOD-1 in plaque. (C, E) Western blot analysis of GPx-1 and SOD-1 in plaque. (D, F) Quantification of band densities showed that plaques from rabbits treated with BMMNCs had significantly higher GPx-1 and SOD-1 protein expression than did plaques from vehicle-treated rabbits. (G–H) BMMNC transplantation reduced expression of cell-death marker cleaved caspase-3 in plaque. (G) Western blot analysis of cleaved caspase-3. (H) Quantification analysis showed that cleaved caspase-3 was significantly lower in plaques from BMMNC-treated rabbits than in plaques from vehicle-treated rabbits. *p<0.05 vs. vehicle group. (I–L) BMMNC transplantation significantly decreased the mRNA expression of proinflammatory cytokines in plaque. (I) Representative RT-PCR bands showing mRNA expression of IL-1 β, TNF-α, and MMP-9 in plaque. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. (J–L) Analysis of band optical densities showed that BMMNC transplantation significantly decreased the mRNA expression of IL-1 β, TNF-α, and MMP-9 compared with that in vehicle-treated animals. *p<0.05 vs. vehicle group. n=6 rabbits per group.
Anti Phospho Enos Ser1177, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca+nos3+human+mouse+monoclonal/Phospho-eNOS+(Ser1177)+Rabbit+mAb/pmc08435524-156-16-26
Average 95 stars, based on 1 article reviews
anti phospho enos ser1177 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

94
Santa Cruz Biotechnology nos3 human
Figure 1. NOS1 splice variant expression of the inner medulla (IM) and cerebellum (CB) from wild-type mouse (WT) and NOS1αKO mouse as determined by Western blotting with anti- NOS1 (C terminus). A, NOS1α is expressed in the cerebellum of the WT mouse but not in the cerebellum of NOS1αKO mice. NOS1β is expressed in the IM of WT and NOS1αKO mice. The molecular weight marker (MW) was run on the same gel, but it was noncontiguous. B, NOS1β and <t>NOS3</t> coexpressed in the IM, and NOS1α and NOS3 coexpressed in the cerebellum of the WT mouse. The molecular weight marker (MW) was run on the same gel, but it was noncontiguous. C, Collecting duct expression of NOS1β in the WT and NOS1αKO mice.
Nos3 Human, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca+nos3+human+mouse+monoclonal/NOS3/10__1161_slash_hypertensionaha__113__01291-192-38-60
Average 94 stars, based on 1 article reviews
nos3 human - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

90
Becton Dickinson purified mouse monoclonal antibody against human enos amino acid 1025–1203
Figure 1. NOS1 splice variant expression of the inner medulla (IM) and cerebellum (CB) from wild-type mouse (WT) and NOS1αKO mouse as determined by Western blotting with anti- NOS1 (C terminus). A, NOS1α is expressed in the cerebellum of the WT mouse but not in the cerebellum of NOS1αKO mice. NOS1β is expressed in the IM of WT and NOS1αKO mice. The molecular weight marker (MW) was run on the same gel, but it was noncontiguous. B, NOS1β and <t>NOS3</t> coexpressed in the IM, and NOS1α and NOS3 coexpressed in the cerebellum of the WT mouse. The molecular weight marker (MW) was run on the same gel, but it was noncontiguous. C, Collecting duct expression of NOS1β in the WT and NOS1αKO mice.
Purified Mouse Monoclonal Antibody Against Human Enos Amino Acid 1025–1203, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca+nos3+human+mouse+monoclonal/mouse+monoclonal+antibody+against+human+enos+amino+acid+1025+1203/pm19797670-66-6-15
Average 90 stars, based on 1 article reviews
purified mouse monoclonal antibody against human enos amino acid 1025–1203 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

93
Bioss rabbit anti endothelial nitric oxide synthase enos
Figure 1. NOS1 splice variant expression of the inner medulla (IM) and cerebellum (CB) from wild-type mouse (WT) and NOS1αKO mouse as determined by Western blotting with anti- NOS1 (C terminus). A, NOS1α is expressed in the cerebellum of the WT mouse but not in the cerebellum of NOS1αKO mice. NOS1β is expressed in the IM of WT and NOS1αKO mice. The molecular weight marker (MW) was run on the same gel, but it was noncontiguous. B, NOS1β and <t>NOS3</t> coexpressed in the IM, and NOS1α and NOS3 coexpressed in the cerebellum of the WT mouse. The molecular weight marker (MW) was run on the same gel, but it was noncontiguous. C, Collecting duct expression of NOS1β in the WT and NOS1αKO mice.
Rabbit Anti Endothelial Nitric Oxide Synthase Enos, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca+nos3+human+mouse+monoclonal/GTP+cyclohydrolase+1+Polyclonal+Antibody/pm37615293-76-18-26
Average 93 stars, based on 1 article reviews
rabbit anti endothelial nitric oxide synthase enos - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc anti enos 6h 2 mouse monoclonal antibody
<t>eNOS</t> and Akt phosphorylation and expression correlate with atheroma stability. Representative western blots and relative densitometric analysis of Α. p-eNOS/ t -eNOS and t -eNOS/β-actin B. Immunohistochemical (IHC) analysis of eNOS in serial sections from stable (n=8) and unstable plaques (n=8). For IHC purposes, frames in 200x magnification pictures represent the areas of 400x magnification. C. p-Akt (S473)/ t -Akt and t -Akt/β-actin (*p<0.05 vs Unstable).
Anti Enos 6h 2 Mouse Monoclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca+nos3+human+mouse+monoclonal/eNOS+Mouse+mAb/pmc05312553-91-10-21
Average 93 stars, based on 1 article reviews
anti enos 6h 2 mouse monoclonal antibody - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

96
New England Biolabs rabbit polyclonal anti phospho nos 3
<t>eNOS</t> and Akt phosphorylation and expression correlate with atheroma stability. Representative western blots and relative densitometric analysis of Α. p-eNOS/ t -eNOS and t -eNOS/β-actin B. Immunohistochemical (IHC) analysis of eNOS in serial sections from stable (n=8) and unstable plaques (n=8). For IHC purposes, frames in 200x magnification pictures represent the areas of 400x magnification. C. p-Akt (S473)/ t -Akt and t -Akt/β-actin (*p<0.05 vs Unstable).
Rabbit Polyclonal Anti Phospho Nos 3, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca+nos3+human+mouse+monoclonal/Anti-SNAP-tag+Antibody/pmc01890348-25-0-6
Average 96 stars, based on 1 article reviews
rabbit polyclonal anti phospho nos 3 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

Image Search Results


BMMNC transplantation reverses atherosclerosis-induced changes in antioxidant enzymes, eNOS, inflammatory response, and cell apoptosis. (A) Western blot analysis of eNOS in plaques. (B) Quantification analysis showed that plaques from the BMMNC group contained more eNOS than did plaques from the vehicle group. (C–F) BMMNC transplantation upregulated expression of the antioxidant enzymes GPx-1 and SOD-1 in plaque. (C, E) Western blot analysis of GPx-1 and SOD-1 in plaque. (D, F) Quantification of band densities showed that plaques from rabbits treated with BMMNCs had significantly higher GPx-1 and SOD-1 protein expression than did plaques from vehicle-treated rabbits. (G–H) BMMNC transplantation reduced expression of cell-death marker cleaved caspase-3 in plaque. (G) Western blot analysis of cleaved caspase-3. (H) Quantification analysis showed that cleaved caspase-3 was significantly lower in plaques from BMMNC-treated rabbits than in plaques from vehicle-treated rabbits. *p<0.05 vs. vehicle group. (I–L) BMMNC transplantation significantly decreased the mRNA expression of proinflammatory cytokines in plaque. (I) Representative RT-PCR bands showing mRNA expression of IL-1 β, TNF-α, and MMP-9 in plaque. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. (J–L) Analysis of band optical densities showed that BMMNC transplantation significantly decreased the mRNA expression of IL-1 β, TNF-α, and MMP-9 compared with that in vehicle-treated animals. *p<0.05 vs. vehicle group. n=6 rabbits per group.

Journal: Molecular neurobiology

Article Title: Autologous bone marrow mononuclear cell transplantation delays progression of carotid atherosclerosis in rabbits

doi: 10.1007/s12035-015-9347-3

Figure Lengend Snippet: BMMNC transplantation reverses atherosclerosis-induced changes in antioxidant enzymes, eNOS, inflammatory response, and cell apoptosis. (A) Western blot analysis of eNOS in plaques. (B) Quantification analysis showed that plaques from the BMMNC group contained more eNOS than did plaques from the vehicle group. (C–F) BMMNC transplantation upregulated expression of the antioxidant enzymes GPx-1 and SOD-1 in plaque. (C, E) Western blot analysis of GPx-1 and SOD-1 in plaque. (D, F) Quantification of band densities showed that plaques from rabbits treated with BMMNCs had significantly higher GPx-1 and SOD-1 protein expression than did plaques from vehicle-treated rabbits. (G–H) BMMNC transplantation reduced expression of cell-death marker cleaved caspase-3 in plaque. (G) Western blot analysis of cleaved caspase-3. (H) Quantification analysis showed that cleaved caspase-3 was significantly lower in plaques from BMMNC-treated rabbits than in plaques from vehicle-treated rabbits. *p<0.05 vs. vehicle group. (I–L) BMMNC transplantation significantly decreased the mRNA expression of proinflammatory cytokines in plaque. (I) Representative RT-PCR bands showing mRNA expression of IL-1 β, TNF-α, and MMP-9 in plaque. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. (J–L) Analysis of band optical densities showed that BMMNC transplantation significantly decreased the mRNA expression of IL-1 β, TNF-α, and MMP-9 compared with that in vehicle-treated animals. *p<0.05 vs. vehicle group. n=6 rabbits per group.

Article Snippet: The primary antibodies were mouse anti-rabbit IGF-1 (1:200, Global Biological Technologies Inc., Shanghai, China), rabbit anti-rabbit IGF-1R (1:100, Biosynthesis), rabbit anti-rabbit eNOS (1:400, Boster), mouse anti-rabbit GPx-1 (1:100, Abcam), goat anti-rabbit SOD-1 (1:1000, Abcam), rabbit anti-rabbit caspase-3 (1:1000, Abcam), and mouse anti-rabbit β-actin (1:500, Boster).

Techniques: Transplantation Assay, Western Blot, Expressing, Marker, Reverse Transcription Polymerase Chain Reaction, Control

Figure 1. NOS1 splice variant expression of the inner medulla (IM) and cerebellum (CB) from wild-type mouse (WT) and NOS1αKO mouse as determined by Western blotting with anti- NOS1 (C terminus). A, NOS1α is expressed in the cerebellum of the WT mouse but not in the cerebellum of NOS1αKO mice. NOS1β is expressed in the IM of WT and NOS1αKO mice. The molecular weight marker (MW) was run on the same gel, but it was noncontiguous. B, NOS1β and NOS3 coexpressed in the IM, and NOS1α and NOS3 coexpressed in the cerebellum of the WT mouse. The molecular weight marker (MW) was run on the same gel, but it was noncontiguous. C, Collecting duct expression of NOS1β in the WT and NOS1αKO mice.

Journal: Hypertension

Article Title: Renal Collecting Duct NOS1 Maintains Fluid–Electrolyte Homeostasis and Blood Pressure

doi: 10.1161/hypertensionaha.113.01291

Figure Lengend Snippet: Figure 1. NOS1 splice variant expression of the inner medulla (IM) and cerebellum (CB) from wild-type mouse (WT) and NOS1αKO mouse as determined by Western blotting with anti- NOS1 (C terminus). A, NOS1α is expressed in the cerebellum of the WT mouse but not in the cerebellum of NOS1αKO mice. NOS1β is expressed in the IM of WT and NOS1αKO mice. The molecular weight marker (MW) was run on the same gel, but it was noncontiguous. B, NOS1β and NOS3 coexpressed in the IM, and NOS1α and NOS3 coexpressed in the cerebellum of the WT mouse. The molecular weight marker (MW) was run on the same gel, but it was noncontiguous. C, Collecting duct expression of NOS1β in the WT and NOS1αKO mice.

Article Snippet: IHC - immunohistochemistry Antibody Sequence Amino Acids Host Application Concentration Company Location NOS1 rat C-terminus rabbit polyclonal IB 20 μg/10ml Santa Cruz Santa Cruz, CA NOS1 human 1414-1434 rabbit polyclonal IB, IHC 1.4 μg Biomol Plymouth Meeting, PA NOS3 human 1025-1203 Mouse monoclonal IB 12.5 μg/ 10ml BD Biosciences San Jose, CA CD3-ε mouse C-terminus goat polyclonal IHC 0.2 μg Santa Cruz Santa Cruz, CA F4/80 mouse ? rat monoclonal IHC 0.1 μg AbD Serotech Raleigh, NC 3 NOS1!"

Techniques: Variant Assay, Expressing, Western Blot, Molecular Weight, Marker

eNOS and Akt phosphorylation and expression correlate with atheroma stability. Representative western blots and relative densitometric analysis of Α. p-eNOS/ t -eNOS and t -eNOS/β-actin B. Immunohistochemical (IHC) analysis of eNOS in serial sections from stable (n=8) and unstable plaques (n=8). For IHC purposes, frames in 200x magnification pictures represent the areas of 400x magnification. C. p-Akt (S473)/ t -Akt and t -Akt/β-actin (*p<0.05 vs Unstable).

Journal: Redox Biology

Article Title: Reciprocal regulation of eNOS, H 2 S and CO-synthesizing enzymes in human atheroma: Correlation with plaque stability and effects of simvastatin

doi: 10.1016/j.redox.2017.02.006

Figure Lengend Snippet: eNOS and Akt phosphorylation and expression correlate with atheroma stability. Representative western blots and relative densitometric analysis of Α. p-eNOS/ t -eNOS and t -eNOS/β-actin B. Immunohistochemical (IHC) analysis of eNOS in serial sections from stable (n=8) and unstable plaques (n=8). For IHC purposes, frames in 200x magnification pictures represent the areas of 400x magnification. C. p-Akt (S473)/ t -Akt and t -Akt/β-actin (*p<0.05 vs Unstable).

Article Snippet: a. Antibodies: For immunohistochemical analysis the following antibodies were used: anti-eNOS (6H 2 ) mouse monoclonal antibody at a 1:100 dilution (Cell Signaling Technology, Beverly, MA, USA), anti- NOX4 (IgG rabbit polyclonal; epitope: a synthetic peptide made to an internal region of the human NOX4 protein (between residues 100–200)) at a 1:50 dilution (Novus-Biologicals, Europe), anti iNOS (Ab-1) (IgG rabbit polyclonal; epitope: purified enzyme from mouse macrophages (RAW 264.7) cells) in dilution 1:100 (Cayman Chemicals, Lab Supplies Greece). b.

Techniques: Phospho-proteomics, Expressing, Western Blot, Immunohistochemical staining

Simvastatin induces eNOS expression and phosphorylation independently of Akt. Representative western blots and relative densitometric analysis of Α. p-eNOS/ t -eNOS and t -eNOS/β-actin B. Immunohistochemical (IHC) analysis of eNOS in serial sections from s/nost (n=8) and s/st (n=8) groups For IHC purposes, frames in 200x magnification pictures represent the areas of 400x magnification. C. p-Akt (S473)/ t -Akt and t -Akt/β-actin (*p<0.05 vs s/nost).

Journal: Redox Biology

Article Title: Reciprocal regulation of eNOS, H 2 S and CO-synthesizing enzymes in human atheroma: Correlation with plaque stability and effects of simvastatin

doi: 10.1016/j.redox.2017.02.006

Figure Lengend Snippet: Simvastatin induces eNOS expression and phosphorylation independently of Akt. Representative western blots and relative densitometric analysis of Α. p-eNOS/ t -eNOS and t -eNOS/β-actin B. Immunohistochemical (IHC) analysis of eNOS in serial sections from s/nost (n=8) and s/st (n=8) groups For IHC purposes, frames in 200x magnification pictures represent the areas of 400x magnification. C. p-Akt (S473)/ t -Akt and t -Akt/β-actin (*p<0.05 vs s/nost).

Article Snippet: a. Antibodies: For immunohistochemical analysis the following antibodies were used: anti-eNOS (6H 2 ) mouse monoclonal antibody at a 1:100 dilution (Cell Signaling Technology, Beverly, MA, USA), anti- NOX4 (IgG rabbit polyclonal; epitope: a synthetic peptide made to an internal region of the human NOX4 protein (between residues 100–200)) at a 1:50 dilution (Novus-Biologicals, Europe), anti iNOS (Ab-1) (IgG rabbit polyclonal; epitope: purified enzyme from mouse macrophages (RAW 264.7) cells) in dilution 1:100 (Cayman Chemicals, Lab Supplies Greece). b.

Techniques: Expressing, Phospho-proteomics, Western Blot, Immunohistochemical staining

Summary of biochemical changes in atheromas.

Journal: Redox Biology

Article Title: Reciprocal regulation of eNOS, H 2 S and CO-synthesizing enzymes in human atheroma: Correlation with plaque stability and effects of simvastatin

doi: 10.1016/j.redox.2017.02.006

Figure Lengend Snippet: Summary of biochemical changes in atheromas.

Article Snippet: a. Antibodies: For immunohistochemical analysis the following antibodies were used: anti-eNOS (6H 2 ) mouse monoclonal antibody at a 1:100 dilution (Cell Signaling Technology, Beverly, MA, USA), anti- NOX4 (IgG rabbit polyclonal; epitope: a synthetic peptide made to an internal region of the human NOX4 protein (between residues 100–200)) at a 1:50 dilution (Novus-Biologicals, Europe), anti iNOS (Ab-1) (IgG rabbit polyclonal; epitope: purified enzyme from mouse macrophages (RAW 264.7) cells) in dilution 1:100 (Cayman Chemicals, Lab Supplies Greece). b.

Techniques:

Reciprocal regulation of eNOS vs H 2 S in atherosclerotic plaques. eNOS-derived NO increases bioavailability of NO in stable plaques, which would be expected to occur due to eNOS upregulation and phosphorylation (due to Akt activation); concomitantly iNOS and NOX-4 are downregulated presumably due to reduced HIF-1α. Moreover CBS and CSE positively correlate with plaque vulnerability. Simvastatin administration decreases HIF-1α expression and its downstream targets, iNOS and HO-1, whereas it increases the phosphorylation and expression of eNOS. Reduced CSE expression is associated with simvastatin administration and enhanced plaque stability (Modified by ). Red color indicates signaling molecules that decreased, whereas green color indicates signaling molecules that are upregulated.

Journal: Redox Biology

Article Title: Reciprocal regulation of eNOS, H 2 S and CO-synthesizing enzymes in human atheroma: Correlation with plaque stability and effects of simvastatin

doi: 10.1016/j.redox.2017.02.006

Figure Lengend Snippet: Reciprocal regulation of eNOS vs H 2 S in atherosclerotic plaques. eNOS-derived NO increases bioavailability of NO in stable plaques, which would be expected to occur due to eNOS upregulation and phosphorylation (due to Akt activation); concomitantly iNOS and NOX-4 are downregulated presumably due to reduced HIF-1α. Moreover CBS and CSE positively correlate with plaque vulnerability. Simvastatin administration decreases HIF-1α expression and its downstream targets, iNOS and HO-1, whereas it increases the phosphorylation and expression of eNOS. Reduced CSE expression is associated with simvastatin administration and enhanced plaque stability (Modified by ). Red color indicates signaling molecules that decreased, whereas green color indicates signaling molecules that are upregulated.

Article Snippet: a. Antibodies: For immunohistochemical analysis the following antibodies were used: anti-eNOS (6H 2 ) mouse monoclonal antibody at a 1:100 dilution (Cell Signaling Technology, Beverly, MA, USA), anti- NOX4 (IgG rabbit polyclonal; epitope: a synthetic peptide made to an internal region of the human NOX4 protein (between residues 100–200)) at a 1:50 dilution (Novus-Biologicals, Europe), anti iNOS (Ab-1) (IgG rabbit polyclonal; epitope: purified enzyme from mouse macrophages (RAW 264.7) cells) in dilution 1:100 (Cayman Chemicals, Lab Supplies Greece). b.

Techniques: Derivative Assay, Phospho-proteomics, Activation Assay, Expressing, Modification